LINDA ARANBAYEVA: Open Payments
NPI 1386310019 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$133 in 7 payments from 3 companies in 2025. Trend: 2023 $281 · 2024 $418 · 2025 $133
Food & beverage: $133
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $74 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Organon LLC | 1 | $15 |
Products named: Veozah, MYFEMBREE, NEXPLANON.
Industry payments across NY — which companies pay providers there.
